We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
A Phase II Study of VP-16-Ifosfamide-Cisplatin Combination Chemotherapy Plus Early Concurrent Thoracic Irradiation for Previously Untreated Limited Small Cell Lung Cancer.
- Authors
Sook Woo; Woo, In Sook; Young Suk Park; Park, Young Suk; Sung Hee Kwon; Kwon, Sung Hee; Park, Young Iee; Young Lee Park; Lee, Jung Ae; Jung Ae Lee; Park, Myung Jae; Myung Jae Park; Hyun, In Gyu; In Gyu Hyun; Jung, Ki Suk; Ki Suk Jung; Bae, Hoon Sik; Hoon Sik Bae; Oh, Do Hoon; Do Hoon Oh
- Abstract
Presents a phase II study of etoposide (VP-16)-ifosfomide-cisplatin(VIP) combination chemotherapy plus early concurrent thoracic irradiation for patients with untreated small cell lung cancer to assess the improvement in the response rate and toxicity. Effects of early and late thoracic irradiation; Comparison of the response rate and survival of the patients.
- Subjects
COMBINATION drug therapy; SMALL cell lung cancer; ANTINEOPLASTIC agents
- Publication
Japanese Journal of Clinical Oncology, 2000, Vol 30, Issue 12, p542
- ISSN
0368-2811
- Publication type
Article
- DOI
10.1093/jjco/hyd135